The Changing Diabetes® in Children (CDiC) programme ensures care and life-saving medicine for children with type 1 diabetes in low and middle income countries. It aims at changing the future for children with type 1 diabetes in these countries. Because no child should die of diabetes!
The CDiC is a public-private partnership programme between Novo Nordisk, Roche, the International Society for Pediatric and Adolescent Diabetes (ISPAD) and the World Diabetes Foundation (WDF). It is being implemented by local partners and national ministries of health.
When few people believe that your disease even exists, the barriers to getting care are many. Changing Diabetes in Children takes more than medicine and the programme addresses the main barriers to create a better tomorrow.
While limited public health data exist on children with type 1 diabetes, the unbearable truth is that only few children live long enough to make it into the registries in low and middle income countries.
As a global leader in diabetes care, we took it upon ourselves to reach 10,000 children with type 1 diabetes living in resource-poor settings when the CDiC programme was initiated in 2009. Since then, we have trained more than 10,000 healthcare providers, established 138 type 1 diabetes clinics and enrolled over 16,000 children in thirteen countries who now live active lives and are educated to take care of their condition.
The original ambition has been doubled to reach 20,000 children with type 1 diabetes by 2020, by expanding the programme to four new countries in 2017 and now totalling thirteen countries. See CDiC project countries map.
If you live with type 1 diabetes, are a parent or if you treat someone with the condition, you probably have questions like:
- Why do I need insulin? - How much insulin should I take and where do I inject it? - How can I measure my blood glucose? - What are hypo- and hyperglycaemia and how to recognise them? - Which foods should I eat? What is my role as a nurse or doctor and how can I best treat and support my patients?
Click on the icons below to get your questions answered (available for download in English, French, Spanish, Swahili, Amharic and Hindi):
More than 1.1 million children and adolescents are living with type 1 diabetes around the world. Many of them live in low- and middle-income countries with limited or no access to diabetes care (IDF, 2017).
Unlike type 2 diabetes, type 1 diabetes is not lifestyle-related and there is no known way to prevent it. People with type 1 diabetes cannot survive without daily doses of insulin and must adhere to a structured self-management plan. In many low-resource countries, children lack access to insulin, blood glucose monitoring and appropriately trained health professionals. This can lead to poor blood glucose control and subsequent severe health complications and early death.